Author

Petra Anna Golovics

RISK OF AND RISK FACTORS FOR COLORECTAL CANCER IN ULCERATIVE COLITIS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2018, DATA FROM THE VESZPREM COUNTY COHORT
RISK OF AND RISK FACTORS FOR COLORECTAL CANCER IN ULCERATIVE COLITIS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2018, DATA FROM THE VESZPREM COUNTY COHORT

RISK OF AND RISK FACTORS FOR COLORECTAL CANCER IN ULCERATIVE COLITIS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2018, DATA FROM THE VESZPREM COUNTY COHORT
RISK OF AND RISK FACTORS FOR COLORECTAL CANCER IN ULCERATIVE COLITIS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2018, DATA FROM THE VESZPREM COUNTY COHORT

Petra Anna Golovics  et al.

UCEIS IS ASSOCIATED WITH PRO2, PARTIAL MAYO AND SCCAI REMISSION IN UC: PRELIMINARY RESULTS FORM A PROSPECTIVE STUDY
UCEIS IS ASSOCIATED WITH PRO2, PARTIAL MAYO AND SCCAI REMISSION IN UC: PRELIMINARY RESULTS FORM A PROSPECTIVE STUDY

Petra Anna Golovics  et al.

PATIENT REPORTED OUTCOMES, PARTIAL MAYO SCORE AND SCCAI ARE EQUALLY ACCURATE IN PREDICTING MUCOSAL HEALING IN UC: PRELIMINARY RESULTS FORM A PROSPECTIVE STUDY
PATIENT REPORTED OUTCOMES, PARTIAL MAYO SCORE AND SCCAI ARE EQUALLY ACCURATE IN PREDICTING MUCOSAL HEALING IN UC: PRELIMINARY RESULTS FORM A PROSPECTIVE STUDY

Petra Anna Golovics  et al.

CLINICAL EFFICACY, THERAPEUTIC DRUG MONITORING AND NOCEBO EFFECT FOLLOWING NON-MEDICAL BIOSIMILAR SWITCH IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE OBSERVATIONAL STUDY
CLINICAL EFFICACY, THERAPEUTIC DRUG MONITORING AND NOCEBO EFFECT FOLLOWING NON-MEDICAL BIOSIMILAR SWITCH IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE OBSERVATIONAL STUDY

Petra Anna Golovics  et al.

DECLINING TRENDS OF REOPERATIONS AND DISEASE BEHAVIOR PROGRESSION BUT NOT FIRST RESECTIVE SURGERY IN CROHN’S DISEASE OVER DIFFERENT THERAPEUTIC ERAS – A PROSPECTIVE POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COHO
DECLINING TRENDS OF REOPERATIONS AND DISEASE BEHAVIOR PROGRESSION BUT NOT FIRST RESECTIVE SURGERY IN CROHN’S DISEASE OVER DIFFERENT THERAPEUTIC ERAS – A PROSPECTIVE POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COHO

Petra Anna Golovics  et al.

BURDEN OF PERIANAL DISEASE AND PERIANAL SURGERY IN CROHN’S DISEASE OVER DIFFERENT THERAPEUTIC ERAS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT
BURDEN OF PERIANAL DISEASE AND PERIANAL SURGERY IN CROHN’S DISEASE OVER DIFFERENT THERAPEUTIC ERAS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT

Petra Anna Golovics  et al.

EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM SURGERY RATES IN CROHN’S DISEASE PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 2007–2018, DATA FROM THE VESZPREM COUNTY COHORT
EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM SURGERY RATES IN CROHN’S DISEASE PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 2007–2018, DATA FROM THE VESZPREM COUNTY COHORT

Petra Anna Golovics  et al.

LONG-TERM RESECTIVE AND PERIANAL SURGERY RATES IN CROHN’S DISEASE OVER DIFFERENT ERAS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT
LONG-TERM RESECTIVE AND PERIANAL SURGERY RATES IN CROHN’S DISEASE OVER DIFFERENT ERAS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT

Petra Anna Golovics  et al.

LONG-TERM COLECTOMY RATES IN ULCERATIVE COLITIS OVER DIFFERENT ERAS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT
LONG-TERM COLECTOMY RATES IN ULCERATIVE COLITIS OVER DIFFERENT ERAS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT

Petra Anna Golovics  et al.

EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM SURGERY RATES IN IBD-U PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 1977–2018, DATA FROM THE VESZPREM COUNTY COHORT
EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM SURGERY RATES IN IBD-U PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 1977–2018, DATA FROM THE VESZPREM COUNTY COHORT

Petra Anna Golovics  et al.

INCIDENCE, EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM SURGERY RATES IN IBD-U PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT
INCIDENCE, EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM SURGERY RATES IN IBD-U PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT

Petra Anna Golovics  et al.

INCIDENCE, PREVALENCE, DISEASE PHENOTYPE AND MAXIMAL THERAPEUTIC STEP IN ULCERATIVE COLITIS PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 2007–2018, DATA FROM THE VESZPREM COUNTY COHORT
INCIDENCE, PREVALENCE, DISEASE PHENOTYPE AND MAXIMAL THERAPEUTIC STEP IN ULCERATIVE COLITIS PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 2007–2018, DATA FROM THE VESZPREM COUNTY COHORT

Petra Anna Golovics  et al.

EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM COLECTOMY RATES IN ULCERATIVE COLITIS PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 2007–2018, DATA FROM THE VESZPREM COUNTY COHORT
EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM COLECTOMY RATES IN ULCERATIVE COLITIS PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 2007–2018, DATA FROM THE VESZPREM COUNTY COHORT

Petra Anna Golovics  et al.

CLINICAL EFFICACY, DRUG SUSTAINABILITY AND RESULTS FROM THERAPEUTIC DRUG MONITORING IN CROHN'S DISEASE PATIENTS TREATED WITH USTEKINUMAB - 1-YEAR FOLLOW-UP OF A PROSPECTIVE, NATIONWIDE, MULTICENTER COHORT FROM HUNGARY
CLINICAL EFFICACY, DRUG SUSTAINABILITY AND RESULTS FROM THERAPEUTIC DRUG MONITORING IN CROHN'S DISEASE PATIENTS TREATED WITH USTEKINUMAB - 1-YEAR FOLLOW-UP OF A PROSPECTIVE, NATIONWIDE, MULTICENTER COHORT FROM HUNGARY

Petra Anna Golovics  et al.

NON-MEDICAL, MANDATORY SWITCH AMONG ADALIMUMAB BIOSIMILARS AND FROM THE ORIGINATOR ADALIMUMAB TO BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE PATIENTS – A PROSPECTIVE, MULTICENTRE STUDY ON EFFICACY, DRUG SUSTAINABILITY AND SAFETY
NON-MEDICAL, MANDATORY SWITCH AMONG ADALIMUMAB BIOSIMILARS AND FROM THE ORIGINATOR ADALIMUMAB TO BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE PATIENTS – A PROSPECTIVE, MULTICENTRE STUDY ON EFFICACY, DRUG SUSTAINABILITY AND SAFETY

Petra Anna Golovics  et al.

Item 1 - 16 / 16
1